The US Justice Department’s (DOJ) Antitrust Division on Monday, September 17, gave its approval to the US$52 billion deal merging Express Scripts with Cigna.
“We are pleased that the Department of Justice has cleared our transaction and that we are another step closer to completing our merger and delivering greater affordability, choice and predictability to our customers and clients as a combined company,” Cigna CEO and President David Cordani said in a media release.
Shareholders voted to approve the merger last month, despite early opposition from activist investor Carl Icahn, who wrote an open letter urging shareholders to reject the deal.He later changed his opinion on the merger. The Justice Department antitrust division said it looked at Cigna’s current PBM services provider, OptumRx, which is owned by UnitedHealth Group. ”
The DOJ Antitrust Division stated it looked at Cigna’s current pharmacy benefit manager (PBM) services provider, OptumRx, which is owned by UnitedHealth Group. “The (DOJ antitrust) Division understands that Cigna intends to use (Express Scripts) for PBM services and that Cigna’s current PBM services provider, UnitedHealthcare’s subsidiary Optum, will be free to compete for PBM customers that purchase medical insurance from Cigna upon closing of the transaction,” The Justice Department announced in a statement Monday.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI